bromodeoxyuridine has been researched along with peplomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamoto, K; Kumazawa, H; Kumazawa, T; Matsumura, H; Wada, Y; Yamashita, T | 1 |
| Iwasaki, Y; Ohara, K; Orii, K; Otsu, H; Sarashina, H; Todoroki, T | 1 |
2 other study(ies) available for bromodeoxyuridine and peplomycin
| Article | Year |
|---|---|
Experimental and clinical evaluation by flow cytometry for the mechanism of combination therapy (cisplatin and peplomycin).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cisplatin; Flow Cytometry; G2 Phase; Humans; In Vitro Techniques; Male; Maxillary Neoplasms; Middle Aged; Peplomycin; S Phase; Tumor Cells, Cultured | 1992 |
Effects of preoperative radiotherapy on rectal cancer. Preliminary report on combining radiation with intratumor injections of peplomycin and bromodeoxyuridine.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bromodeoxyuridine; Clinical Protocols; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Peplomycin; Preoperative Care; Radiotherapy Dosage; Rectal Neoplasms; Survival Rate | 1990 |